###begin article-title 0
Angiotensin-converting-enzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease
###end article-title 0
###begin p 1
###xml 488 489 486 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 577 578 571 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 733 734 725 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 6 13 <span type="species:ncbi:4097">tobacco</span>
While tobacco smoking is the main risk factor for chronic obstructive pulmonary disease (COPD) only a fraction of smokers go on to develop the disease. We investigated the relationship between the insertion (I) - deletion (D) polymorphisms in the Angiotensin converting enzyme (ACE) gene and the risk of developing COPD in smokers by determining the distribution of the ACE genotypes (DD, ID and II) in 151 life-long male smokers. 74 of the smokers had developed COPD (62 +/- 2 years; FEV1 44 +/- 6 % reference) whereas the rest retained normal lung function (56 +/- 2 yrs; FEV1 95 +/- 3 % reference). In addition, we genotyped 159 males recruited randomly from the general population. The prevalence of the DD genotype was highest (p = 0.01) in the smokers that developed COPD and its presence was associated with a 2-fold increase in the risk for COPD (OR 2.2; IC95% 1.1 to 5.5). Surprisingly, the 151 individuals in the smoking population did not demonstrate Hardy-Weinberg equilibrium unlike the 159 recruited from the general population. Our results suggest that ACE polymorphisms are associated with both the smoking history of an individual and their risk of developing COPD.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 157 178 157 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19-copd-2-329">Murray and Lopez 1997</xref>
###xml 304 315 304 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3-copd-2-329">Barnes 2000</xref>
###xml 431 442 431 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-copd-2-329">Barnes 1999</xref>
###xml 534 535 530 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 560 586 556 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29-copd-2-329">Silverman and Speizer 1996</xref>
###xml 181 188 <span type="species:ncbi:4097">Tobacco</span>
###xml 369 376 <span type="species:ncbi:4097">tobacco</span>
Chronic obstructive pulmonary disease (COPD) is now the sixth largest cause of death in the world and it's prevalence is expected to increase in the future (Murray and Lopez 1997). Tobacco smoking is the main risk factor for COPD but despite this only a fraction of smokers go on to develop the disease (Barnes 2000). While it has been suggested that susceptibility to tobacco smoke may reflect a genetic component of the disease (Barnes 1999) the only genetic factor identified so far in predisposing individuals to COPD is the alpha1-antitrypsin deficiency (Silverman and Speizer 1996).
###end p 3
###begin p 4
###xml 268 284 268 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33-copd-2-329">Woods et al 2000</xref>
###xml 322 338 322 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4-copd-2-329">Brice et al 1995</xref>
###xml 340 355 340 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30-copd-2-329">Ucar et al 1997</xref>
The Angiotensin-converting enzyme (ACE) is a zinc metallo-peptidase that is highly expressed in lungs, where it degrades bradykinin and catalyses the formation of the Angiotensin II (AII); a powerful vasoconstrictor, inflammatory modulator and cellular growth factor (Woods et al 2000). ACE activity is increased in COPD (Brice et al 1995; Ucar et al 1997) but it remains to be established whether this is a cause or consequence of the disease process.
###end p 4
###begin p 5
###xml 196 212 196 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25-copd-2-329">Rigat et al 1992</xref>
###xml 289 305 289 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-copd-2-329">Rigat et al 1990</xref>
###xml 307 325 307 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5-copd-2-329">Busjahn et al 1998</xref>
###xml 327 345 327 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7-copd-2-329">Chagani et al 1999</xref>
###xml 347 368 347 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18-copd-2-329">Montgomery et al 1999</xref>
###xml 445 461 445 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4-copd-2-329">Brice et al 1995</xref>
###xml 463 478 463 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30-copd-2-329">Ucar et al 1997</xref>
###xml 435 443 <span type="species:ncbi:9606">patients</span>
The ACE gene is located in chromosome 17q23 and shows a functional polymorphism consisting of an insertion (I) or deletion (D) of a 287bp fragment that determines three genotypes (DD, ID and II) (Rigat et al 1992) where the presence of the D allele is associated with higher ACE activity (Rigat et al 1990; Busjahn et al 1998; Chagani et al 1999; Montgomery et al 1999). Given that previous studies show increased ACE activity in COPD patients (Brice et al 1995; Ucar et al 1997) the aim of the present study was to test the hypothesis that the DD genotype is more prevalent in smokers that develop COPD.
###end p 5
###begin title 6
Methods
###end title 6
###begin title 7
Population and ethics
###end title 7
###begin p 8
###xml 162 163 160 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 196 204 <span type="species:ncbi:9606">patients</span>
###xml 817 829 <span type="species:ncbi:9606">Participants</span>
We genotyped 151 male life-long smokers, 74 of whom had developed moderate-severe COPD (FEV1 44 +/- 6 %reference) and the rest retaining normal lung function (FEV1 95 +/- 3 % reference). All COPD patients were in a stable phase of the disease (not having had an exacerbation for, at least, three months preceding their inclusion to the study. We exclude subjects with other chronic lung diseases (asthma, bronchiectasis, lung cancer and interstitial lung diseases) and/or chronic extrapulmonary disorders such as, diabetes, arterial hypertension, cancer, immune diseases and cardiac, hepatic or renal failure. In addition, we genotyped 159 healthy males recruited randomly from the general population. All individuals were from the Balearic Islands and belonged to the same Caucasian Mediterranean ethnic background. Participants were not relatives and all gave informed consent to the study that was approved by the ethical review board of the Hospital Universitari Son Dureta.
###end p 8
###begin title 9
Lung function
###end title 9
###begin p 10
###xml 115 133 115 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27-copd-2-329">Sanchis et al 1989</xref>
###xml 199 214 199 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-copd-2-329">Roca et al 1986</xref>
Forced spirometry (GS, Warren E Collins, Braintree, MA, USA) was determined according to international guidelines (Sanchis et al 1989) and reference values were those for a Mediterranean population (Roca et al 1986).
###end p 10
###begin title 11
ACE genotyping
###end title 11
###begin p 12
###xml 368 383 360 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31-copd-2-329">Ueda et al 1996</xref>
###xml 487 505 479 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25-copd-2-329">Rigat et al (1992)</xref>
###xml 586 587 578 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-copd-2-329">1</xref>
###xml 669 687 661 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-copd-2-329">Evans et al (1994)</xref>
###xml 771 772 763 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-copd-2-329">1</xref>
Genomic DNA was extracted from venous blood using standard methods (Promega, Madison, WI, USA) and stored at -80masculineC for subsequent analysis. The ACE genotype was determined using the polymerase chain reaction (PCR).Since the D allele can be more effectively amplified than the longer I allele, increasing the potential for ID individuals to be genotyped as DD (Ueda et al 1996), we used two different genotyping methods. Initially, the genotype was determined using the method of Rigat et al (1992) where the PCR products were a 190 bp (allele D) and a 490 bp (allele I) (Figure 1, Panel a). Subsequently, the genotype was confirmed with the method described by Evans et al (1994)where the amplified products were a 84 bp (allele D) and a 65 bp (allele I) (Figure 1, Panel b).
###end p 12
###begin title 13
Statistical analysis
###end title 13
###begin p 14
###xml 606 607 606 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Results are shown for continuous variables as mean and its standard error, and for discrete variables as percentages. Quantitative variables were compared between groups using ANOVA. Genotype distributions were compared between smokers with and without COPD using Pearson's Chi-Square test, from which the odds ratio (OR) and the 95% confidence interval (95% CI) were calculated. Genotype frequencies were compared with values predicted by Hardy-Weinberg equilibrium equation (p2 + 2pq + q2 = 1) by the Chi-Square test, where p is frequency of dominant allele D and q is frequency of recessive allele d. A p value of less than 0.05 was considered significant.
###end p 14
###begin title 15
Results
###end title 15
###begin p 16
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1-copd-2-329">1</xref>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1-copd-2-329">1</xref>
Age, smoking exposure and body mass index were similar in smokers with and without COPD (Table 1) and, by definition, the smokers with COPD showed characteristics of airflow obstruction (Table 1).
###end p 16
###begin p 17
###xml 98 99 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2-copd-2-329">2</xref>
###xml 261 262 261 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 224 232 <span type="species:ncbi:9606">patients</span>
The distribution of the ACE genotypes in smokers that developed COPD was significantly different (p = 0.023) from those with normal lung function (Table 2). As hypothesized, the DD genotype was found to be more prevalent in patients with COPD (36.5% vs. 16.9%, p = 0.01) and the presence of the DD genotype in a smoker was calculated to give a 2-fold increase in the risk of developing COPD (OR 2.2; IC95% 1.1 to 5.5).
###end p 17
###begin p 18
###xml 89 90 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 236 249 236 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34-copd-2-329">Xu et al 2002</xref>
###xml 555 556 555 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3-copd-2-329">3</xref>
###xml 786 787 786 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 851 852 851 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3-copd-2-329">3</xref>
Surprisingly, we found Hardy-Weinberg disequilibrium in the smoking population (n = 151, p = 0.001). Deviations from this equilibrium can be caused by either genotyping errors and/or stratifications within the population being studied (Xu et al 2002) and we excluded the first possibility by using two different genotyping techniques. To address the second possibility, we further genotyped 159 randomly recruited individuals from the same population as our smokers and found their distribution of ACE genotypes to be in Hardy Weinberg equilibrium (Table 3). This observation further supports the validity of our genotyping techniques but more importantly, suggests that smoking may be associated with the ACE genotype. In fact, an excess of the heterozygote (ID) was found in smokers (p = 0.05) irrespective of whether they had developed COPD (Table 3).
###end p 18
###begin title 19
Discussion
###end title 19
###begin p 20
This study shows that the DD ACE genotype is associated with an increased risk of a smoker to developing COPD and, unexpectedly, that the ACE heterozygote is more prevalent in individuals that smoke.
###end p 20
###begin title 21
ACE and COPD
###end title 21
###begin p 22
###xml 232 253 232 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32-copd-2-329">van Suylen et al 1999</xref>
###xml 255 274 255 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14-copd-2-329">Kanazawa et al 2000</xref>
###xml 276 296 276 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11-copd-2-329">Hopkinson et al 2004</xref>
###xml 508 524 508 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4-copd-2-329">Brice et al 1995</xref>
###xml 526 541 526 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30-copd-2-329">Ucar et al 1997</xref>
###xml 640 656 640 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-copd-2-329">Rigat et al 1990</xref>
###xml 658 676 658 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5-copd-2-329">Busjahn et al 1998</xref>
###xml 678 696 678 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7-copd-2-329">Chagani et al 1999</xref>
###xml 698 719 698 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18-copd-2-329">Montgomery et al 1999</xref>
###xml 883 899 883 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4-copd-2-329">Brice et al 1995</xref>
###xml 901 916 901 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30-copd-2-329">Ucar et al 1997</xref>
###xml 1007 1023 1007 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4-copd-2-329">Brice et al 1995</xref>
###xml 1025 1040 1025 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30-copd-2-329">Ucar et al 1997</xref>
###xml 873 881 <span type="species:ncbi:9606">patients</span>
Previous studies have shown an association between ACE genotype and several phenotypic characteristics of COPD, for example, the development of pulmonary vascular remodelling, right ventricular failure and skeletal muscle strength (van Suylen et al 1999; Kanazawa et al 2000; Hopkinson et al 2004). To our knowledge, however, this is the first study to show that the presence of the DD genotype increases the risk of a smoker developing chronic airflow obstruction. Plasma ACE activity is increased in COPD (Brice et al 1995; Ucar et al 1997) and while we did not measure it here the D allele is associated with higher plasma ACE activity (Rigat et al 1990; Busjahn et al 1998; Chagani et al 1999; Montgomery et al 1999). The high prevalence of the DD genotype observed in the smokers that developed COPD is therefore consistent with increased plasma ACE activity in these patients (Brice et al 1995; Ucar et al 1997). More importantly, our results suggest that the increased ACE activity reported in COPD (Brice et al 1995; Ucar et al 1997) can be related to the genotype and is not a consequence of the disease (leading to translational or post-translational modification of the protein).
###end p 22
###begin p 23
###xml 322 338 322 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-copd-2-329">Rigat et al 1990</xref>
###xml 340 358 340 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5-copd-2-329">Busjahn et al 1998</xref>
###xml 360 378 360 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7-copd-2-329">Chagani et al 1999</xref>
###xml 380 401 380 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18-copd-2-329">Montgomery et al 1999</xref>
###xml 550 561 550 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-copd-2-329">Barnes 1999</xref>
###xml 563 567 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3-copd-2-329">2000</xref>
###xml 658 673 658 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9-copd-2-329">Guba et al 2000</xref>
###xml 731 747 731 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28-copd-2-329">Selby et al 1991</xref>
###xml 749 773 749 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15-copd-2-329">Keatings and Barnes 1997</xref>
###xml 862 879 862 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35-copd-2-329">Zafari et al 1998</xref>
###xml 925 940 925 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20-copd-2-329">Myou et al 2000</xref>
###xml 1008 1029 1008 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10-copd-2-329">Hatakeyama et al 1994</xref>
###xml 1133 1149 1133 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33-copd-2-329">Woods et al 2000</xref>
Our study was not designed to investigate the potential mechanisms linking the ACE genotype to the pathogenesis of COPD. However, several possibilities can be conceived to explain a higher risk of COPD among smokers who carry the DD genotype. As discussed earlier, the presence of the D allele will increase ACE activity (Rigat et al 1990; Busjahn et al 1998; Chagani et al 1999; Montgomery et al 1999) and, in turn, cause higher Angiotensin II (AII) levels. Increased AII levels will contribute to the inflammatory response that characterizes COPD (Barnes 1999, 2000) by (1) up-regulating expression of the endothelial adhesion molecules ICAM-1 and VCAM-1 (Guba et al 2000) and facilitating neutrophil retention within the lungs (Selby et al 1991; Keatings and Barnes 1997), (2) activating the neutrophil respiratory burst and contributing to oxidative stress (Zafari et al 1998), (3) enhancing airway hyper-responsiveness (Myou et al 2000), (4) regulating vascular smooth-muscle cell growth and migration (Hatakeyama et al 1994), that may contribute to pulmonary hypertension in COPD and (5) modulating tissue repair and fibrosis (Woods et al 2000).
###end p 23
###begin title 24
ACE and smoking
###end title 24
###begin p 25
We found that our smoking population was in Hardy-Weinberg disequilibrium and are confident that this did not result from genotyping errors or population stratification due to the reasons given previously.
###end p 25
###begin p 26
###xml 1008 1026 1008 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-copd-2-329">Nielsen et al 1998</xref>
###xml 1104 1105 1104 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3-copd-2-329">3</xref>
###xml 1365 1383 1365 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12-copd-2-329">Hubacek et al 2001</xref>
There are a number of assumptions required to evaluate whether the genotype distribution within a population fulfils the requirements for Hardy - Weinberg equilibrium, namely that the gene is located in a somatic chromosome, the organism has discrete generations, there is random mating within a single population and an infinite population size (or sufficiently large so as to minimize the effect of genetic drift). Finally, there should be experiences of no selection, no mutation, and no migration (gene flow). We believe all apply in the populations studied here; however, replication by different investigators in different populations would be welcome to identify any causal link between the ACE gene and COPD. Departure from Hardy-Weinberg equilibrium also occurs when the selection criteria are based on disease-susceptibility genotypes rather than on independently selected alleles. In fact, marker-disease association can be detected by testing for Hardy-Weinberg disequilibrium at a marker locus (Nielsen et al 1998). Therefore, to explain the excess ID genotype observed among smokers (Table 3), we propose the existence of linkage disequilibrium between the trait of being a life-long smoker and the ACE locus. This interpretation is supported by a recent study showing that the ACE ID polymorphism influences the amount of cigarettes smoked per week (Hubacek et al 2001).
###end p 26
###begin p 27
###xml 302 303 302 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3-copd-2-329">3</xref>
###xml 439 440 439 440 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 459 460 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 480 494 480 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-copd-2-329">Lee et al 2002</xref>
###xml 496 504 496 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16-copd-2-329">Lee 2003</xref>
Molecular heterosis occurs when heterozygous subjects for a given polymorphism show a significantly greater or lesser effect for a trait than in homozygous subjects for either allele. We found molecular heterosis in smokers, where a significant proportion of individuals carried the ID genotype (Table 3). It is worth noting here that molecular heterosis (and Hardy-Weinberg disequilibrium) has also been found in studies of the dopamine D2 receptor gene (DRD2) in smoking males (Lee et al 2002; Lee 2003).
###end p 27
###begin p 28
###xml 158 177 158 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23-copd-2-329">Pontieri et al 1996</xref>
###xml 179 198 179 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22-copd-2-329">Pontieri et al 1998</xref>
###xml 200 220 200 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-copd-2-329">Alcantara et al 2003</xref>
###xml 238 253 238 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36-copd-2-329">Zhou et al 2001</xref>
###xml 320 338 320 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13-copd-2-329">Jenkins et al 1997</xref>
###xml 340 355 340 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36-copd-2-329">Zhou et al 2001</xref>
The biological basis of nicotine dependence is not fully understood, but it is well established that nicotine stimulates the central dopamine reward pathway (Pontieri et al 1996; Pontieri et al 1998; Alcantara et al 2003). Like nicotine (Zhou et al 2001), Angiotensin II also modulates dopamine release in the striatum (Jenkins et al 1997; Zhou et al 2001) and it is likely that the ACE gene is involved in the regulation of the dopamine reward pathway. This provides a mechanistic basis for the interpretation of our observation of Hardy-Weinberg disequilibrium and molecular heterosis in smokers.
###end p 28
###begin title 29
Conclusion
###end title 29
###begin p 30
Our study shows, first, that the presence of the DD ACE genotype increases the risk of smokers going on to develop COPD and, second, that smoking is linked to a Hardy-Weinberg disequilibrium in the allelic distribution of the ACE gene consistent with it playing a role in smoking addiction.
###end p 30
###begin p 31
Supported, in part, by FIS 00/0437, FIS 02/3008and RTIC C03/11 (Red Respira); CICYT PB98-1084, SEPAR and ABEMAR.
###end p 31
###begin p 32
XB and NGM equally contributed to this work.
###end p 32
###begin title 33
References
###end title 33
###begin article-title 34
###xml 118 121 <span type="species:ncbi:10116">rat</span>
Localization of dopamine D2 receptors on cholinergic interneurons of the dorsal striatum and nucleus accumbens of the rat
###end article-title 34
###begin article-title 35
Molecular genetics of chronic obstructive pulmonary disease
###end article-title 35
###begin article-title 36
Chronic obstructive pulmonary disease
###end article-title 36
###begin article-title 37
Serum angiotensin-converting enzyme activity, concentration, and specific activity in granulomatous interstitial lung disease, tuberculosis, and COPD
###end article-title 37
###begin article-title 38
Angiotensin-converting enzyme and angiotensinogen gene polymorphisms and heart rate variability in twins
###end article-title 38
###begin article-title 39
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
###end article-title 39
###begin article-title 40
Prevalence of tumor necrosis factor-alpha and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near-fatal asthma
###end article-title 40
###begin article-title 41
Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease
###end article-title 41
###begin article-title 42
Differential effects of short-term ace- and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro
###end article-title 42
###begin article-title 43
Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells
###end article-title 43
###begin article-title 44
Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease
###end article-title 44
###begin article-title 45
Angiotensin converting enzyme gene-a candidate gene for addiction to smoking?
###end article-title 45
###begin article-title 46
Angiotensin-converting enzyme modulates dopamine turnover in the striatum
###end article-title 46
###begin article-title 47
###xml 140 148 <span type="species:ncbi:9606">patients</span>
Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease
###end article-title 47
###begin article-title 48
Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects
###end article-title 48
###begin article-title 49
Gender-specific molecular heterosis and association studies: dopamine D2 receptor gene and smoking
###end article-title 49
###begin article-title 50
Gender-specific molecular heterosis of dopamine D2 receptor gene (DRD2) for smoking in schizophrenia
###end article-title 50
###begin article-title 51
Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training
###end article-title 51
###begin article-title 52
Mortality by cause for eight regions of the world: Global Burden of Disease Study
###end article-title 52
###begin article-title 53
Type 1 angiotensin II receptor antagonism reduces antigen-induced airway reactions
###end article-title 53
###begin article-title 54
Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus
###end article-title 54
###begin article-title 55
Functional correlates of nicotine administration: similarity with drugs of abuse
###end article-title 55
###begin article-title 56
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs
###end article-title 56
###begin article-title 57
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
###end article-title 57
###begin article-title 58
###xml 60 65 <span type="species:ncbi:9606">human</span>
PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)
###end article-title 58
###begin article-title 59
Spirometric reference values from a Mediterranean population
###end article-title 59
###begin article-title 60
Normativa para la practica de la espirometria forzada
###end article-title 60
###begin article-title 61
###xml 37 45 <span type="species:ncbi:9606">patients</span>
Neutrophil retention in the lungs of patients with chronic obstructive pulmonary disease
###end article-title 61
###begin article-title 62
Risk factors for the development of chronic obstructive pulmonary disease
###end article-title 62
###begin article-title 63
Serum angiotensin converting enzyme activity in pulmonary diseases: correlation with lung function parameters
###end article-title 63
###begin article-title 64
###xml 17 22 <span type="species:ncbi:9606">human</span>
Mistyping of the human angiotensin-converting enzyme gene polymorphism: frequency, causes and possible methods to avoid errors in typing
###end article-title 64
###begin article-title 65
###xml 126 134 <span type="species:ncbi:9606">patients</span>
The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease
###end article-title 65
###begin article-title 66
###xml 29 34 <span type="species:ncbi:9606">human</span>
The ACE I/D polymorphism and human physical performance
###end article-title 66
###begin article-title 67
Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error?
###end article-title 67
###begin article-title 68
###xml 36 37 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 38 39 38 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy
###end article-title 68
###begin article-title 69
Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum
###end article-title 69
###begin p 70
###xml 50 57 50 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Panel a</bold>
###xml 122 140 122 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25-copd-2-329">Rigat et al (1992)</xref>
###xml 288 295 288 295 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Panel b</bold>
###xml 360 378 360 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-copd-2-329">Evans et al (1994)</xref>
Determination of DD, ID, and II genotypes by PCR. Panel a shows a representative experiment using the method described by Rigat et al (1992). PCR products are a 190 bp fragment (D genotype) and a 490 bp fragment (I genotype). Heterozygotes (ID) have both the 190 bp and 490 bp fragments. Panel b shows a representative experiment using the method described by Evans et al (1994). PCR products are a 84 bp (D genotype) and a 65 bp (I genotype). Heterozygotes (ID) have both the 84 bp and 65 bp fragments.
###end p 70
###begin p 71
Clinical and functional data of the two life-long smoker groups
###end p 71
###begin p 72
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p < 0.001
###end p 72
###begin p 73
Distribution of the ACE genotypes in the different groups studied
###end p 73
###begin p 74
Allele/Genotype frequencies and test of Hardy-Weinberg (HW) equilibrium
###end p 74
###begin p 75
###xml 162 163 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 184 185 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
f = observed frequency of each allele (D or I); O = observed genotype numbers; E = expected genotype numbers under a Hardy-Weinberg (HW) equilibrium assumption; X2= Chi-square values; P = probability of difference
###end p 75

